IL133209A - Microcrystalline cellulose alginate pharmaceutical suspensions - Google Patents

Microcrystalline cellulose alginate pharmaceutical suspensions

Info

Publication number
IL133209A
IL133209A IL13320998A IL13320998A IL133209A IL 133209 A IL133209 A IL 133209A IL 13320998 A IL13320998 A IL 13320998A IL 13320998 A IL13320998 A IL 13320998A IL 133209 A IL133209 A IL 133209A
Authority
IL
Israel
Prior art keywords
suspension
weight
suspending agent
formulation
pharmaceutical
Prior art date
Application number
IL13320998A
Other languages
English (en)
Other versions
IL133209A0 (en
Original Assignee
Fmc Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fmc Corp filed Critical Fmc Corp
Publication of IL133209A0 publication Critical patent/IL133209A0/xx
Publication of IL133209A publication Critical patent/IL133209A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IL13320998A 1997-06-04 1998-05-29 Microcrystalline cellulose alginate pharmaceutical suspensions IL133209A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/869,039 US5840768A (en) 1997-06-04 1997-06-04 MCC: alginate pharmaceutical suspensions
PCT/US1998/010961 WO1998055102A1 (en) 1997-06-04 1998-05-29 Microcrystalline cellulose: alginate pharmaceutical suspensions

Publications (2)

Publication Number Publication Date
IL133209A0 IL133209A0 (en) 2001-03-19
IL133209A true IL133209A (en) 2004-06-20

Family

ID=25352819

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13320998A IL133209A (en) 1997-06-04 1998-05-29 Microcrystalline cellulose alginate pharmaceutical suspensions

Country Status (13)

Country Link
US (1) US5840768A (no)
EP (1) EP0998266B1 (no)
JP (1) JP2002511079A (no)
CN (1) CN1158992C (no)
AT (1) ATE250925T1 (no)
AU (1) AU737686B2 (no)
CA (1) CA2291719A1 (no)
DE (1) DE69818669D1 (no)
IL (1) IL133209A (no)
NO (1) NO995942L (no)
TR (1) TR199902961T2 (no)
TW (1) TW528604B (no)
WO (1) WO1998055102A1 (no)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6211246B1 (en) * 1999-06-10 2001-04-03 Mcneil-Ppc, Inc. Rapidly absorbed liquid compositions
AU2001275784A1 (en) * 2000-08-02 2002-02-13 Malope Company Limited Diagnosis and treatment of non-ulcer dyspepsia based on hypothalamic-pituitary-adrenal axis abnormality
US7300670B2 (en) * 2002-04-03 2007-11-27 Unilab Pharmatech, Ltd. Oral suspension formulation
US20040258716A1 (en) * 2002-06-17 2004-12-23 Shen Gao Ibuprofen suspension
TWI327913B (en) * 2003-03-12 2010-08-01 Novartis Ag Pharmaceutical composition comprising 5-methyl-2-(2'-chloro-6'-fluoroanilino)phenylacetic acid
CN101991531B (zh) * 2010-11-09 2012-06-27 武汉人福药业有限责任公司 布洛芬口服混悬液及其制备方法
CN102921038B (zh) * 2012-08-06 2014-07-09 西南交通大学 制备具有形状记忆功能的多孔支架的方法
CN114650401B (zh) 2020-12-21 2024-07-19 中强光电股份有限公司 投影装置

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4263334A (en) * 1978-05-31 1981-04-21 Fmc Corporation Water dispersible cellulosic powder and method of making the same
US4427681A (en) * 1982-09-16 1984-01-24 Richardson-Vicks, Inc. Thixotropic compositions easily convertible to pourable liquids
US5366742A (en) * 1993-05-03 1994-11-22 Fmc Corporation Colloidal microcrystalline cellulose and barrier dispersant composition and method for manufacture
US5605712A (en) * 1995-09-29 1997-02-25 Fmc Corporation Stabilizer compositions, frozen desserts containing the same and stabilizing method

Also Published As

Publication number Publication date
IL133209A0 (en) 2001-03-19
US5840768A (en) 1998-11-24
CN1278163A (zh) 2000-12-27
TR199902961T2 (xx) 2000-06-21
JP2002511079A (ja) 2002-04-09
WO1998055102A1 (en) 1998-12-10
EP0998266B1 (en) 2003-10-01
DE69818669D1 (de) 2003-11-06
CN1158992C (zh) 2004-07-28
TW528604B (en) 2003-04-21
CA2291719A1 (en) 1998-12-10
NO995942L (no) 2000-02-02
NO995942D0 (no) 1999-12-03
AU737686B2 (en) 2001-08-30
ATE250925T1 (de) 2003-10-15
AU7703698A (en) 1998-12-21
EP0998266A1 (en) 2000-05-10

Similar Documents

Publication Publication Date Title
US4975465A (en) Orally administrable ibuprofen compositions
US4427681A (en) Thixotropic compositions easily convertible to pourable liquids
US5759579A (en) Pharmaceutical suspension systems
US5658919A (en) Aqueous pharmaceutical suspension and process for preparation thereof
CA1340529C (en) Pediatric ibuprofen compositions
MXPA06013481A (es) Composicion de suspension farmaceutica.
US3282789A (en) Stable liquid colloidal tannate compositions
US20040258716A1 (en) Ibuprofen suspension
US5840768A (en) MCC: alginate pharmaceutical suspensions
KR100217928B1 (ko) 프라노프로펜 함유 현탁제 조성물
JP2004099558A (ja) 医薬用ゼリー組成物
US4468381A (en) Concentrated magnesium hydroxide preparations
US4837211A (en) Spironolactone composition
JPH09187233A (ja) ゼリー組成物
CA2540869A1 (en) Spill resistant formulations containing clays
EP0468232B1 (en) Suspending syrups
AU771516B2 (en) Drinkable ibuprofen pharmaceutical suspension
US20030176394A1 (en) Pepsin inhibition by alginates
AU778364B2 (en) Drinkable pharmaceutical solution
JP2004099559A (ja) 医薬用ゼリー組成物
RU2173139C2 (ru) Усовершенствования органических композиций или усовершенствования, относящиеся к этим композициям
JPH0516405B2 (no)
JPH10287565A (ja) プラノプロフェン懸濁シロップ剤
GB2049418A (en) Pharmaceutical antacid compositions

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees